Skip to Content

Notice

Notice of Meeting: Secretary's Advisory Committee on Generic Testing

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to Public Law 92-463, notice is hereby given of the seventh meeting of the Secretary's Advisory Committee on Genetic Testing (SACGT), U.S. Public Health Service. The meeting will be held from 9 a.m. to 3:15 p.m. on February 15, 2001 and 10:15 a.m. to 4:30 p.m. on February 16, 2001 at the National Institutes of Health, Building 31, C Wing, Conference Room 10, 9000 Rockville Pike, Bethesda, MD 20892. The meeting will be open to the public with attendance limited to space available.

The Committee will discuss a number of topics, including a proposed classification methodology for genetic tests; a draft genetic test information template for health professionals; and a draft white paper on genetics education for health professionals. Breakout sessions are scheduled for SACGT's working groups to meet and discuss ongoing and future projects. The Committee will be updated on the working groups' activities and progress during the full Committee meeting. The Committee will also hear an update on the activities of the Food and Drug Administration. There will be a limited period of time provided for public comment and interested individuals Start Printed Page 7916should notify the contact person listed below.

Under authority of 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established SACGT to advise and make recommendations to the Secretary through the Assistant Secretary for Health on all aspects of the development and use of genetic tests. The SACGT is directed to (1) recommend policies and procedures for the safe and effective incorporation of genetic technologies into health care; (2) assess the effectiveness of existing and future measures for oversight of genetic tests; and (3) identify research needs related to the Committee's purview.

The draft meeting agenda and other information about SACGT will be available at the following web site: http://www4.od.nih.gov/​oba/​sacgt.htm. Individuals who wish to provide public comments or who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the SACGT Executive Secretary, Ms. Sarah Carr, by telephone at 301-496-9838 or E-mail at sc112c@nih.gov. The SACGT office is located at 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892.

Start Signature

Dated: January 11, 2001.

Sarah Carr,

Executive Secretary, SACGT.

End Signature End Preamble

[FR Doc. 01-2326 Filed 1-25-01; 8:45 am]

BILLING CODE 4140-01-M